Earnings Call Summary | Aspen Aerogels(ASPN.US) Q1 2024 Earnings Conference
Earnings Call Summary | Aspen Aerogels(ASPN.US) Q1 2024 Earnings Conference
The following is a summary of the Aspen Aerogels, Inc. (ASPN) Q1 2024 Earnings Call Transcript:
以下是阿斯彭氣凝膠公司（ASPN）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Aspen Aerogels reported a significant revenue increase, from $84 million in Q4 2023 to nearly $95 million in Q1 2024.
Their EV PyroThin thermal barrier revenue has seen exponential growth, doubling annually from $7 million in 2021 to $110 million in 2023.
The company's gross margin continues to expand, reaching 37% in the most recent quarter.
Adjusted EBITDA improved by a notable $27 million comparing Q1 2024 to Q1 2023.
The company projects total revenues of at least $380 million for 2024, a 59% year-over-year increase from 2023 and a 9% increase over their prior revenue baseline for 2024.
The company anticipates delivering over $11 million of operating income, translating into over $55 million of adjusted EBITDA.
The expected 2024 net income is over $2 million or $0.03 per share, based on a share count of 76.5 million shares.
Expected Capital expenditure (CapEx), excluding Plant II, is to be maintained at $50 million for 2024.
Aspen Aerogels報告收入大幅增長，從2023年第四季度的8400萬美元增加到2024年第一季度的近9500萬美元。
他們的電動車 PyroThin 隔熱板收入呈指數級增長，從 2021 年的 700 萬美元翻一番，到 2023 年的 1.1 億美元。
該公司的毛利率繼續擴大，在最近一個季度達到37％。
與2024年第一季度與2023年第一季度相比，調整後的息稅折舊攤銷前利潤顯著增加了2700萬美元。
該公司預計，2024年的總收入至少爲3.8億美元，比2023年同比增長59％，比之前的2024年的收入基準增長9％。
該公司預計實現超過1100萬美元的營業收入，相當於超過5,500萬美元的調整後息稅折舊攤銷前利潤。
根據7,650萬股股票，預計2024年的淨收入超過200萬美元，合每股收益0.03美元。
2024年，不包括二號工廠在內的預期資本支出（CapEx）將維持在5000萬美元。
Business Progress:
業務進展：
Aspen Aerogels intends to transition to its External Manufacturing Facility, targeting to supply nearly 100% of the product for the energy industrial business by H2 2024.
The company's advancing manufacturing operations include full conversion of Plant 1 in East Providence, Rhode Island for the growth of the PyroThin business, and the planned construction of a second aerogel manufacturing facility in Georgia.
Recognition for their advancements in Aerogel technology is evident in the award of the Automotive News PACE Prize for their PyroThin cell-to-cell thermal barrier products.
The company's business is projected to grow with ongoing conversations with nearly 20 different OEM programs, the expected announcement of additional OEM wins, and discussions on awarding a sixth OEM.
Aspen Aerogels maintained its focus on cost management and balance sheet optimization while being cautious of broader long-term industry dynamics.
Their supply lines include prototype parts for the Toyota bZ4X, its Subaru and Lexus variants, and ongoing dialogue with General Motors.
Aspen Aerogels打算過渡到其外部製造工廠，目標是到2024年下半年爲能源工業業務提供近100％的產品。
該公司推進的製造業務包括全面改建位於羅德島州東普羅維登斯的1號工廠，以促進PyroThin業務的增長，以及計劃在佐治亞州建造第二座氣凝膠製造工廠。
他們的PyroThin電池間隔熱屏障產品榮獲汽車新聞PACE獎，這體現了他們在氣凝膠技術方面的進步的認可。
隨着與近20個不同的OEM項目的持續對話、預計將宣佈更多OEM獲獎以及關於授予第六家OEM的討論，公司的業務預計將增長。
Aspen Aerogels繼續專注於成本管理和資產負債表優化，同時對更廣泛的長期行業動態持謹慎態度。
他們的供應線包括豐田bZ4x的原型零件、斯巴魯和雷克薩斯變體，以及與通用汽車的持續對話。
More details: Aspen Aerogels IR
更多詳情： Aspen 氣凝膠 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。